Delay in adjuvant chemoradiation impacts survival outcome in glioblastoma multiforme patients
- PMID: 31573367
- DOI: 10.1080/0284186X.2019.1672893
Delay in adjuvant chemoradiation impacts survival outcome in glioblastoma multiforme patients
Similar articles
-
Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution.J Korean Med Sci. 2015 Nov;30(11):1597-603. doi: 10.3346/jkms.2015.30.11.1597. Epub 2015 Oct 16. J Korean Med Sci. 2015. PMID: 26539003 Free PMC article.
-
Survival Analysis of Glioblastoma Multiforme.Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2613-2617. doi: 10.22034/APJCP.2018.19.9.2613. Asian Pac J Cancer Prev. 2018. PMID: 30256068 Free PMC article.
-
Commentary on "Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme".Strahlenther Onkol. 2015 Mar;191(3):281-2. doi: 10.1007/s00066-014-0788-9. Strahlenther Onkol. 2015. PMID: 25487693 No abstract available.
-
High-grade astrocytomas.Neurol Clin. 1995 Nov;13(4):875-900. Neurol Clin. 1995. PMID: 8584002 Review.
-
Glioblastoma multiforme: evidence-based approach to therapy.Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S23-7. doi: 10.1586/14737140.7.12s.S23. Expert Rev Anticancer Ther. 2007. PMID: 18076314 Review.
Cited by
-
Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendations.Sci Rep. 2023 Feb 16;13(1):2766. doi: 10.1038/s41598-023-29790-8. Sci Rep. 2023. PMID: 36797335 Free PMC article.
-
State of the neoadjuvant therapy for glioblastoma multiforme-Where do we stand?Neurooncol Adv. 2024 Mar 5;6(1):vdae028. doi: 10.1093/noajnl/vdae028. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38560349 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical